诚意药业
(603811)
| 流通市值：38.13亿 | | | 总市值：38.13亿 |
| 流通股本：3.27亿 | | | 总股本：3.27亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 205,125,531.51 | 198,670,494.92 | 172,683,012.67 | 173,037,913.66 |
| 应收票据及应收账款 | 38,689,631.8 | 43,667,028.01 | 39,679,124.7 | 32,959,369.27 |
| 其中：应收票据 | - | - | - | 50,000 |
| 应收账款 | 38,689,631.8 | 43,667,028.01 | 39,679,124.7 | 32,909,369.27 |
| 应收款项融资 | 8,267,515.57 | 31,597,659.33 | 9,979,727 | 39,952,790.52 |
| 预付款项 | 7,293,958.41 | 7,792,498.5 | 8,841,183.55 | 8,610,753.26 |
| 其他应收款合计 | 2,097,975.28 | 2,008,909.75 | 4,043,601.69 | 6,471,053.08 |
| 存货 | 125,324,247.36 | 104,746,481.72 | 118,406,392.38 | 131,843,548.31 |
| 其他流动资产 | 570,576.59 | 240,922.68 | 234,442.54 | 523,476.2 |
| 流动资产合计 | 396,179,491.32 | 388,948,786.18 | 354,092,275.8 | 393,623,695.57 |
| 非流动资产: | | | | |
| 长期股权投资 | 331,720,790.68 | 323,651,971.73 | 324,362,009.21 | 314,867,199.27 |
| 投资性房地产 | 900,656.56 | 930,682.03 | 960,707.5 | 990,732.97 |
| 固定资产 | 883,529,252.79 | 901,493,283.82 | 921,605,278.77 | 940,521,058.01 |
| 在建工程 | 11,162,572.38 | 7,244,740.72 | 7,103,661.08 | 5,149,260.06 |
| 使用权资产 | - | - | - | 16,491.34 |
| 无形资产 | 53,512,130.05 | 62,730,720.25 | 63,340,157.59 | 63,949,594.93 |
| 长期待摊费用 | 246,234.94 | 299,603.98 | 352,973.02 | 406,342.06 |
| 递延所得税资产 | 5,727,088.96 | 5,264,809.41 | 4,938,144.63 | 6,298,303 |
| 其他非流动资产 | 8,616,780 | 4,641,260 | 3,431,207.31 | 2,558,072.65 |
| 非流动资产合计 | 1,295,415,506.36 | 1,306,257,071.94 | 1,326,094,139.11 | 1,334,757,054.29 |
| 资产总计 | 1,691,594,997.68 | 1,695,205,858.12 | 1,680,186,414.91 | 1,728,380,749.86 |
| 流动负债: | | | | |
| 短期借款 | 55,095,534.72 | 55,096,333.33 | 50,095,500 | 51,100,780.56 |
| 应付票据及应付账款 | 49,890,303.32 | 54,707,241.06 | 51,957,453.39 | 84,669,674.42 |
| 其中：应付票据 | - | 1,017,200 | 1,017,200 | - |
| 应付账款 | 49,890,303.32 | 53,690,041.06 | 50,940,253.39 | 84,669,674.42 |
| 合同负债 | 8,530,345.02 | 10,769,510.86 | 9,167,755.33 | 12,221,076.33 |
| 应付职工薪酬 | 13,821,079.55 | 11,608,441.22 | 17,446,472.85 | 23,285,902.83 |
| 应交税费 | 17,900,057.26 | 26,010,169.81 | 17,621,650.06 | 21,317,672.24 |
| 其他应付款合计 | 125,608,730.26 | 62,275,835.78 | 53,628,865.75 | 56,906,664.36 |
| 一年内到期的非流动负债 | 3,062,533.84 | 32,934,391.6 | 25,199,650.92 | 40,448,699.69 |
| 其他流动负债 | 1,085,002.45 | 1,375,462.58 | 1,167,640.88 | 1,553,250.04 |
| 流动负债合计 | 274,993,586.42 | 254,777,386.24 | 226,284,989.18 | 291,503,720.47 |
| 非流动负债: | | | | |
| 长期借款 | 58,608,000 | 119,758,000 | 118,508,000 | 139,308,000 |
| 递延收益 | 16,598,631.32 | 17,304,221.62 | 17,986,187.47 | 18,766,750.48 |
| 递延所得税负债 | 12,510,611.65 | 12,919,066.4 | 13,327,521.18 | 13,735,975.95 |
| 非流动负债合计 | 87,717,242.97 | 149,981,288.02 | 149,821,708.65 | 171,810,726.43 |
| 负债合计 | 362,710,829.39 | 404,758,674.26 | 376,106,697.83 | 463,314,446.9 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 327,304,320 | 327,304,320 | 327,304,320 | 327,304,320 |
| 资本公积 | 122,654,383.22 | 142,998,487.16 | 142,998,487.16 | 142,998,487.16 |
| 减:库存股 | 48,286,356 | 76,397,831.64 | 75,118,432.64 | 67,263,133.8 |
| 盈余公积 | 138,586,838.77 | 138,586,838.77 | 138,586,838.77 | 138,586,838.77 |
| 未分配利润 | 781,760,120.8 | 751,460,213.24 | 764,251,145.9 | 718,457,975.29 |
| 归属于母公司股东权益合计 | 1,322,019,306.79 | 1,283,952,027.53 | 1,298,022,359.19 | 1,260,084,487.42 |
| 少数股东权益 | 6,864,861.5 | 6,495,156.33 | 6,057,357.89 | 4,981,815.54 |
| 股东权益合计 | 1,328,884,168.29 | 1,290,447,183.86 | 1,304,079,717.08 | 1,265,066,302.96 |
| 负债和股东权益合计 | 1,691,594,997.68 | 1,695,205,858.12 | 1,680,186,414.91 | 1,728,380,749.86 |
| 公告日期 | 2025-10-28 | 2025-08-27 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |